NFGH
Nan Fung Group Holdings Portfolio holdings
AUM
$63.4M
This Quarter Return
+4.72%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(+4.9%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
9.47%
Top 10 Holdings %
Top 10 Hldgs %
64.1%
Holding
36
New
1
Increased
9
Reduced
2
Closed
1
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$5.87M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$1.74M |
| 3 |
Oculis Holding
OCS
|
$1.49M |
| 4 |
argenx
ARGX
|
$1.4M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$966K |
Top Sells
| 1 |
Rubrik
RBRK
|
$1.59M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.16M |
| 3 |
Incyte
INCY
|
$484K |
Sector Composition
| 1 | Healthcare | 99.8% |
| 2 | Materials | 0.2% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Revolution Medicines
RVMD
$7.1B
| $681K | 0.56% |
19,253
| – | – |
|
27
Rani Therapeutics
RANI
$24.4M
| $622K | 0.51% |
493,584
| – | – |
|
|
BCYC
28
Bicycle Therapeutics
BCYC
$511M
| $585K | 0.48% |
68,943
| – | – |
|
|
CLYM
29
Climb Bio, Inc. Common Stock
CLYM
$151M
| $566K | 0.46% |
463,654
| – | – |
|
30
Bolt Biotherapeutics
BOLT
$9.85M
| $467K | 0.38% |
1,166,952
| – | – |
|
31
Entrada Therapeutics
TRDA
$208M
| $444K | 0.36% |
49,082
| – | – |
|
|
DBVT
32
DBV Technologies
DBVT
$264M
| $253K | 0.21% |
37,095
| – | – |
|
|
BSLK
33
Bolt Projects Holdings, Inc. Common Stock
BSLK
$13.5M
| $250K | 0.2% |
811,952
| – | – |
|
|
AFMD
34
DELISTED
Affimed
AFMD
| $26.9K | 0.02% |
37,247
| – | – |
|
35
ALX Oncology
ALXO
$62.7M
| $26.1K | 0.02% |
41,950
| – | – |
|
|
36
Rubrik
RBRK
$17.3B
| – | – |
-24,338
| Closed | -$1.59M |
|